Boston Scientific announced today that the FDA approved an expanded indication for its WaveWriter spinal cord stimulation (SCS) systems. The indication covers chronic low back and leg pain in people without prior back surgery — called non-surgical back pain (NSBP). Boston Scientific says first-line treatment for people with chronic back pain tends to have limitations. […]
Spine
Globus Medical lays off 157 at former NuVasive headquarters
Globus Medical (NYSE:GMED) is letting go of 157 workers at NuVasive’s former headquarters campus in San Diego, according to a WARN report filed with the state of California. The notice, dated Jan. 3 and shared by the California Employment Development Department with MassDevice, says the campus will stay open. Workers received notice of the layoffs on […]
Boston Scientific has positive spinal cord stimulation data
Boston Scientific announced positive one-year results from a trial evaluating its spinal cord stimulation (SCS) technology. The SOLIS randomized control trial demonstrated sustained pain relief with the WaveWriter Alpha SCS system for treating non-surgical back pain (NSBP). Boston Scientific presented data at the 2024 North American Neuromodulation Society (NANS) meeting in Las Vegas. Dr. James […]
Accelus picks up $20M to support expandable spine implant tech
Accelus announced that it received a significant financial investment through a $20 million debt facility from Symbiotic Capital. Palm Beach Gardens, Florida-based Accelus says the strategic funding represents a critical milestone in the company’s journey. It aims to establish itself as the global market leader in expandable spinal implant solutions. Adding the capital strengthens its […]
Nevro earns coverage win for spinal cord stimulation
Nevro (NYSE:NVRO) announced that Carelon Healthcare plans to expand its spinal cord stimulation (SCS) coverage. Carelon plans to publish a new interventional pain management policy expanding SCS coverage for painful diabetic neuropathy (PDN). The policy, set to go into effect on April 14, increases PDN patient coverage by nearly 43 million additional lives. Payers that […]
Medtronic has positive spinal cord stimulation data
Medtronic today announced data from two clinical trials supporting its spinal cord stimulation (SCS) technologies. The medtech giant shared data at the North American Neuromodulation Society (NANS) annual meeting in Las Vegas. Results demonstrated the benefits of SCS in patients with chronic low back pain (CLBP) and leg pain. The company also plans to highlight […]
Orthofix partners with MRIguidance on orthopedic imaging
Orthofix Medical announced today that it agreed with MRIguidance to distribute its imaging software in the U.S. The Lewisville, Texas–based company agreed to distribute the BoneMRI software in the U.S. It also announced the successful completion of the world’s first eight cases using BoneMRI with its 7D Flash navigation system. BoneMRI creates a synthetic CT […]
Onward begins neurostim study to address post-spinal cord injury hemodynamic instability
Onward Medical announced today that it began the HemON NL clinical feasibility study to evaluate its ARC-IM neurostimulation therapy. Onward said that, in late 2023, a study participant received the investigational ARC-IM neurostimulator and lead implant. This study aims to assess the safety and effectiveness of the therapy to address hemodynamic instability after spinal cord […]
Orthofix has a new CFO as Massimo Caliafiore takes over as CEO
Orthofix Medical announced that it appointed a new CFO as its newly appointed CEO takes over the corner office. The large orthopedic device maker appointed Julie Andrews as CFO as Massimo Calafiore assumes his position as CEO. Orthofix named Calafiore as its next CEO in November. However, the company had to wait until Enovis completed […]
Orthofix has positive spine stimulation tech data
Orthofix Medical today announced new data investigating pulsed electromagnetic field (PEMF) stimulation with lumbar spinal fusion. Lewisville, Texas-based Orthofix evaluated PEMF stimulation as an adjunct to lumbar spinal fusion procedures in patients at risk for pseudoarthrosis. Patients treated with the SpinalStim bone growth device demonstrated a high rate of successful fusion. They also showed significant […]
ZimVie to sell spine business, become pure-play dental company
ZimVie announced today that it agreed to sell its spine business to investment firm H.I.G. Capital. Shares of ZIMV skyrocketed more than 50% to $17.05 apiece by the afternoon. MassDevice‘s MedTech 100 Index was up slightly. The sale of the business, valued at $375 million, establishes ZimVie as a pure-play dental company. Westminster, Colorado-based ZimVie […]